ArticleBMC health services research2026
Dynamic evaluation and continuous improvement model of pharmaceutical administration based on DPSIR-TOPSIS.
Article in BMC health services research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study aimed to evaluate the dynamic development of pharmaceutical administration at Beijing Chaoyang Hospital from 2019 to 2024 and to identify key influencing and optimization factors using a data-driven analytical framework.
methodsAn integrated “entropy weight–TOPSIS”model was constructed based on the DPSIR (Driving force–Pressure–State–Impact–Responses) framework. The model quantified trends in pharmaceutical administration performance using multi-dimensional indicators, including policy, resource allocation, drug utilization, and pharmacist capacity.
resultsThe composite pharmaceutical administration index showed an overall upward trend from 2019 to 2024, with a temporary decline during the early COVID-19 period. Subsequent recovery was associated with improved drug use policies and management coordination. From 2022 onward, healthcare reforms, the “One Hospital, Three Campuses” operational model, and the adoption of smart pharmacy technologies were linked to reduced operational pressures, enhanced system responsiveness, and improved cost control and medication safety.
conclusionPharmaceutical administration at Beijing Chaoyang Hospital demonstrated continuous progress. Future optimization should emphasize comprehensive antibacterial drug management, a multidimensional incentive mechanism to enhance the use of essential medicines, and the advancement of smart pharmacy systems to enhance pharmacists’ professional value and sustain high-quality pharmaceutical administration development.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.